Search

Your search keyword '"Epidermal growth factors -- Analysis"' showing total 47 results

Search Constraints

Start Over You searched for: Descriptor "Epidermal growth factors -- Analysis" Remove constraint Descriptor: "Epidermal growth factors -- Analysis" Topic editors Remove constraint Topic: editors
47 results on '"Epidermal growth factors -- Analysis"'

Search Results

1. Studies Conducted at Technical University Munich (TU Munich) on Breast Cancer Recently Published (Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor ...)

2. Studies from Ankara University Add New Findings in the Area of Non-Small Cell Lung Cancer (Evaluation of Epidermal Growth Factor Receptor Mutations and Thyroid Transcription Factor-1 Status In Turkish Non-small Cell Lung Carcinoma Patients: a ...)

3. Researchers at S. Orsola-Malpighi University Hospital Target Cancer (Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis)

4. Reports Outline Lung Cancer Study Results from Toulouse University (Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer)

5. New Glioblastomas Data Have Been Reported by Researchers at Sungkyunkwan University School of Medicine (Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry)

6. New Findings from Kidwai Memorial Institute of Oncology in the Area of Squamous Cell Carcinoma Reported (Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cell-free tumor DNA using next ...)

7. Studies from L. Alifrangis et al Add New Findings in the Area of Solid Cancer (Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic ...)

8. Studies from Medical Faculty Have Provided New Data on Lung Cancer (Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor)

9. Investigators at National Center for Radiation Research and Technology Release New Data on Breast Cancer (Assessment of human epidermal growth factor receptor 2/neu gene amplification and expression as a biomarker for radiotherapy and ...)

10. Reports Summarize Biomarkers Study Results from M. Kriegs and Co-Researchers (Analyzing expression and phosphorylation of the EGF receptor in HNSCC)

11. Findings from Kyushu University Provides New Data about Non-Small Cell Lung Cancer (Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor ...)

12. Recent Studies from Sungkyunkwan University School of Medicine Add New Data to Peptide Receptors (Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing: A Direct Comparison ...)

13. Findings from Department of Thoracic Medical Oncology Yields New Data on Non-Small Cell Lung Cancer (Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases)

14. Findings from Department of Pathology in Kinase Inhibitors Reported (Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor)

15. Study Data from Medical University of Gdansk Provide New Insights into Colon Cancer (Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines)

16. Data on Squamous Cell Carcinoma Reported by E. Tsiamb and Colleagues (Combined Egfr/alk Expression Analysis In Laryngeal Squamous Cell Carcinoma)

17. Research Conducted at Nantes University Hospital Has Provided New Information about Receptor Protein-Tyrosine Kinases (Circulating Free Tumor-derived Dna To Detect Egfr Mutations In Patients With Advanced Nsclc: French Subset Analysis of the ...)

18. Researchers at University of Tokyo Have Reported New Data on Lung Cancer (Mathematical Analysis of Gefitinib Resistance of Lung Adenocarcinoma Caused By Met Amplification)

19. Investigators from School of Bio Sciences and Technology Target Receptor Protein-Tyrosine Kinases (3d Structure Prediction of Vapc1 and Identification of Dual Natural Inhibitors for Vpac1 and Egfr)

20. Findings from Weifang Medical University Provide New Insights into Lung Cancer (Bim Deletion Polymorphism Predicts Poor Response To Egfr-tkis In Nonsmall Cell Lung Cancer: an Updated Meta-analysis)

21. Data on Lung Cancer Described by Researchers at Qingdao University (The Diagnostic Value of Quantitative Ct Analysis of Ground-glass Volume Percentage In Differentiating Epidermal Growth Factor Receptor Mutation and Subtypes In Lung ...)

22. Study Results from University of Ulsan College of Medicine in the Area of Lung Cancer Reported (Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer)

23. Studies from Hallym University Update Current Data on Non-Small Cell Lung Cancer (Correlation of Thyroid Transcription Factor-1 Expression With Egfr Mutations In Non-small-cell Lung Cancer: a Meta-analysis)

24. Research Conducted at University of Texas Has Provided New Information about Breast Cancer (Assessing Metastatic Potential of Breast Cancer Cells Based On Egfr Dynamics)

25. Studies from Indiana University School of Medicine Update Current Data on Non-Small Cell Lung Cancer (Molecular Testing for Egfr Mutations and Alk Rearrangements In the Cytological Specimens From the Patients With Non-small Cell Lung Cancer)

26. Reports from Department of Hematology-Oncology Advance Knowledge in Breast Cancer (Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2-negative breast cancer: A meta-analysis of randomized controlled trials)

27. Reports on Non-Small Cell Lung Cancer Findings from City University of Hong Kong Provide New Insights (Hydrogen Bond Analysis of the Egfr-erbb3 Heterodimer Related To Non-small Cell Lung Cancer and Drug Resistance)

28. New Kinase Inhibitors Findings from Kindai University Outlined (Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro)

29. Findings from Austin Health Update Knowledge of Non-Small Cell Lung Cancer (EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive ...)

30. Study Data from Department of Gynecology Provide New Insights into Women's Health (Effects of trastuzumab on the proliferation and apoptosis of ovarian cancer cells)

31. Researchers from National Cancer Institute Detail Findings in Lung Cancer [Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma]

32. Findings in Colon Cancer Reported from Department of Hematology & Oncology (Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer)

33. New Lung Cancer Study Findings Have Been Reported from Shantou Central Hospital (Front-line Therapy in Advanced Non-Small Cell Lung Cancer With Sensitive Epidermal Growth Factor Receptor Mutations: A Network Meta-analysis)

34. Studies from First Affiliated Hospital of Chongqing Medical University Have Provided New Data on Kinase Inhibitors (Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse ...)

35. Researchers from Huazhong University of Science and Technology Discuss Findings in Acute Lung Injury (Erlotinib Protects LPS-Induced Acute Lung Injury in Mice by Inhibiting EGFR/TLR4 Signaling Pathway)

36. Researchers at Institute Jules Bordet Target Breast Cancer (Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial)

37. New Liver Cancer Findings Reported from Zhejiang Provincial People' s Hospital (Inhibitory Effects of Genistein In Combination With Gefitinib On the Hepatocellular Carcinoma Hep3b Cell Line)

38. Data on Peptide Receptors Detailed by Researchers at Sungkyunkwan University School of Medicine (Osimertinib for patients with leptomeningeal metastases associated with epidermal growth factor receptor T790M positive advanced NSCLC: the AURA LM ...)

39. New Memory Disorders Study Results from Council of Scientific and Industrial Research (CSIR) Described (Estrogen Deficiency Induces Memory Loss Via Altered Hippocampal Hb-egf and Autophagy)

40. Researchers at Second Military Medical University Have Reported New Data on Lung Cancer (The Prognostic Value of Tumor Mutation Burden In Egfr-mutant Advanced Lung Adenocarcinoma, an Analysis Based On Cbioportal Data Base)

41. Medical Oncology Service Reports Findings in Colon Cancer (Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials)

42. Reports from Dankook University Provide New Insights into Colon Cancer (Whole Transcriptome Analysis Identifies TNS4 as a Key Effector of Cetuximab and a Regulator of the Oncogenic Activity of KRAS Mutant Colorectal Cancer Cell Lines)

43. Study Findings from INJE University Provide New Insights into Gastric Cancer (Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma)

44. Studies Conducted at Sungkyunkwan University School of Medicine on Non-Small Cell Lung Cancer Recently Reported (Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer)

45. Recent Findings from Department of Gynecology and Obstetrics Has Provided New Information about Pancreatic Cancer (Expression of Tmeff2 In Human Pancreatic Cancer Tissue and the Effects of Tmeff2 Knockdown On Cell, Proliferation, and Apoptosis ...)

46. Studies from Affiliated Hospital 2 Have Provided New Information about Receptor Protein-Tyrosine Kinases (The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms)

47. New Peptide Receptors Study Findings Have Been Reported by Researchers at Affiliated Hospital (Urinary and Plasma Cell-Free DNA Comparison for Lung Cancer Patients Treated With Epidermal Growth Factor Receptor-Thyroxine Kinase Inhibitors)

Catalog

Books, media, physical & digital resources